A single center experience of prenatal parent‐fetus trio exome sequencing for pregnancies with congenital anomalies

Objectives To examine the diagnostic yield of trio exome sequencing in fetuses with multiple structural defects with no pathogenic findings in cytogenetic and microarray analyses. Methods We recruited 51 fetuses with two or more defects, non‐immune fetal hydrops or fetal akinesia deformation syndrom...

Full description

Saved in:
Bibliographic Details
Published in:Prenatal diagnosis 2022-06, Vol.42 (7), p.901-910
Main Authors: Dufke, Andreas, Hoopmann, Markus, Waldmüller, Stephan, Prodan, Natalia Carmen, Beck‐Wödl, Stefanie, Grasshoff, Ute, Heinrich, Tilman, Riess, Angelika, Kehrer, Martin, Falb, Ruth J., Liebmann, Alexandra, Roggia, Cristiana, Stampfer, Miriam, Schadeck, Malou, Müller, Amelie J., Grimmel, Mona, Stöbe, Petra, Gauck, Darja, Buchert‐Lo, Rebecca, Baumann, Sarah, Schäferhoff, Karin, Bertrand, Miriam, Menden, Benita, Sturm, Marc, Schütz, Leon, Riess, Olaf, Ossowski, Stephan, Haack, Tobias B., Kagan, Karl Oliver
Format: Article
Language:English
Subjects:
Abnormalities
Akinesia
Congenital anomalies
Congenital defects
Cytogenetics
Defects
Deformation
DNA microarrays
DNA sequencing
Edema
Fetuses
Genetic analysis
Gestational age
Nucleotide sequence
Pregnancy
Zebrafish
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives To examine the diagnostic yield of trio exome sequencing in fetuses with multiple structural defects with no pathogenic findings in cytogenetic and microarray analyses. Methods We recruited 51 fetuses with two or more defects, non‐immune fetal hydrops or fetal akinesia deformation syndrome|or fetal akinesia deformation sequence (FADS). Trio exome sequencing was performed on DNA from chorionic villi samples and parental blood. Detection of genomic variation and prioritization of clinically relevant variants was performed according to in‐house standard operating procedures. Results Median maternal and gestational age was 32.0 years and 21.0 weeks, respectively. Forty‐three (84.3%) fetuses had two or more affected organ systems. The remaining fetuses had isolated fetal hydrops or FADS. In total, the exome analysis established the genetic cause for the clinical abnormalities in 22 (43.1%, 95% CI 29.4%–57.8%) pregnancies. Conclusions In fetuses with multiple defects, hydrops or FADS and normal standard genetic results, trio exome sequencing has the potential to identify genetic anomalies in more than 40% of cases. Key points What's already known about this topic? Genome‐wide sequencing for unspecific heterogeneous syndromic and non‐syndromic congenital conditions increases the diagnostic yield compared with standard genetic testing in both the pre‐ and postnatal settings. The diagnostic yield prenatally varies depending on selection criteria and number of anomalies present. What does this study add? Trio exome sequencing should be considered for fetuses with normal cytogenetic and micro‐array analysis and two or more organ defects, fetal hydrops or fetal akinesia syndromes. Selection of cases for exome sequencing should be based on expert prenatal imaging.
ISSN:0197-3851
1097-0223
DOI:10.1002/pd.6170